TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,099,267 | +20.4% | 71,058 | +22.3% | 0.13% | +23.5% |
| Q2 2023 | $912,987 | -8.9% | 58,115 | -4.5% | 0.10% | -14.3% |
| Q1 2023 | $1,002,709 | +6.4% | 60,844 | +0.8% | 0.12% | -4.8% |
| Q4 2022 | $941,959 | +14.5% | 60,382 | -4.9% | 0.12% | +4.2% |
| Q3 2022 | $823,000 | +50.7% | 63,479 | +63.1% | 0.12% | +57.9% |
| Q2 2022 | $546,000 | +38.6% | 38,919 | +41.5% | 0.08% | +58.3% |
| Q1 2022 | $394,000 | +10.1% | 27,504 | +25.9% | 0.05% | -5.9% |
| Q3 2021 | $358,000 | +0.8% | 21,842 | +3.6% | 0.05% | -3.8% |
| Q2 2021 | $355,000 | +86.8% | 21,074 | +103.1% | 0.05% | +3.9% |
| Q1 2021 | $190,000 | +15.2% | 10,378 | +14.4% | 0.05% | +15.9% |
| Q4 2020 | $165,000 | – | 9,072 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |